397 related articles for article (PubMed ID: 30924311)
1. Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit.
Hocine HR; Brunel S; Chen Q; Giustiniani J; San Roman MJ; Ferrat YJ; Palacios I; de la Rosa O; Lombardo E; Bensussan A; Charron D; Jabrane-Ferrat N; Al-Daccak R
Stem Cells Transl Med; 2019 Sep; 8(9):911-924. PubMed ID: 30924311
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence.
Boukouaci W; Lauden L; Siewiera J; Dam N; Hocine HR; Khaznadar Z; Tamouza R; Borlado LR; Charron D; Jabrane-Ferrat N; Al-Daccak R
Cardiovasc Res; 2014 Nov; 104(2):290-302. PubMed ID: 25213554
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts.
Lima Correa B; El Harane N; Gomez I; Rachid Hocine H; Vilar J; Desgres M; Bellamy V; Keirththana K; Guillas C; Perotto M; Pidial L; Alayrac P; Tran T; Tan S; Hamada T; Charron D; Brisson A; Renault NK; Al-Daccak R; Menasché P; Silvestre JS
Cardiovasc Res; 2021 Jan; 117(1):292-307. PubMed ID: 32049348
[TBL] [Abstract][Full Text] [Related]
4. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1.
Lauden L; Boukouaci W; Borlado LR; López IP; Sepúlveda P; Tamouza R; Charron D; Al-Daccak R
Circ Res; 2013 Feb; 112(3):451-64. PubMed ID: 23243206
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Progenitor Cell-Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation.
Maring JA; Lodder K; Mol E; Verhage V; Wiesmeijer KC; Dingenouts CKE; Moerkamp AT; Deddens JC; Vader P; Smits AM; Sluijter JPG; Goumans MJ
J Cardiovasc Transl Res; 2019 Feb; 12(1):5-17. PubMed ID: 30456736
[TBL] [Abstract][Full Text] [Related]
6. Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.
Balbi C; Lodder K; Costa A; Moimas S; Moccia F; van Herwaarden T; Rosti V; Campagnoli F; Palmeri A; De Biasio P; Santini F; Giacca M; Goumans MJ; Barile L; Smits AM; Bollini S
Int J Cardiol; 2019 Jul; 287():87-95. PubMed ID: 30987834
[TBL] [Abstract][Full Text] [Related]
7. Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair.
Dam N; Hocine HR; Palacios I; DelaRosa O; Menta R; Charron D; Bensussan A; El Costa H; Jabrane-Ferrat N; Dalemans W; Lombardo E; Al-Daccak R
Front Immunol; 2017; 8():1413. PubMed ID: 29123530
[TBL] [Abstract][Full Text] [Related]
8. Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.
Hocine HR; Costa HE; Dam N; Giustiniani J; Palacios I; Loiseau P; Bensussan A; Borlado LR; Charron D; Suberbielle C; Jabrane-Ferrat N; Al-Daccak R
Sci Rep; 2017 Jan; 7():41125. PubMed ID: 28117403
[TBL] [Abstract][Full Text] [Related]
9. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors.
El Harane N; Kervadec A; Bellamy V; Pidial L; Neametalla HJ; Perier MC; Lima Correa B; Thiébault L; Cagnard N; Duché A; Brunaud C; Lemitre M; Gauthier J; Bourdillon AT; Renault MP; Hovhannisyan Y; Paiva S; Colas AR; Agbulut O; Hagège A; Silvestre JS; Menasché P; Renault NKE
Eur Heart J; 2018 May; 39(20):1835-1847. PubMed ID: 29420830
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN.
Vrijsen KR; Maring JA; Chamuleau SA; Verhage V; Mol EA; Deddens JC; Metz CH; Lodder K; van Eeuwijk EC; van Dommelen SM; Doevendans PA; Smits AM; Goumans MJ; Sluijter JP
Adv Healthc Mater; 2016 Oct; 5(19):2555-2565. PubMed ID: 27570124
[TBL] [Abstract][Full Text] [Related]
12. Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation.
Balbi C; Costa A; Barile L; Bollini S
Cells; 2020 Mar; 9(3):. PubMed ID: 32183455
[TBL] [Abstract][Full Text] [Related]
13. Characterization of βARKct engineered cellular extracellular vesicles and model specific cardioprotection.
Kwon JS; Schumacher SM; Gao E; Chuprun JK; Ibetti J; Roy R; Khan M; Kishore R; Koch WJ
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1276-H1289. PubMed ID: 33513081
[TBL] [Abstract][Full Text] [Related]
14. P2Y
Khalafalla FG; Greene S; Khan H; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Nguyen J; Norman B; Dembitsky WP; Sussman MA
Circ Res; 2017 Nov; 121(11):1224-1236. PubMed ID: 28923792
[TBL] [Abstract][Full Text] [Related]
15. Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF.
Wysoczynski M; Pathan A; Moore JB; Farid T; Kim J; Nasr M; Kang Y; Li H; Bolli R
Stem Cell Rev Rep; 2019 Aug; 15(4):530-542. PubMed ID: 31102187
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure.
Kervadec A; Bellamy V; El Harane N; Arakélian L; Vanneaux V; Cacciapuoti I; Nemetalla H; Périer MC; Toeg HD; Richart A; Lemitre M; Yin M; Loyer X; Larghero J; Hagège A; Ruel M; Boulanger CM; Silvestre JS; Menasché P; Renault NK
J Heart Lung Transplant; 2016 Jun; 35(6):795-807. PubMed ID: 27041495
[TBL] [Abstract][Full Text] [Related]
17. Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition.
Huang G; Cheng Z; Hildebrand A; Wang C; Cimini M; Roy R; Lucchese AM; Benedict C; Mallaredy V; Magadum A; Joladarashi D; Thej C; Gonzalez C; Trungcao M; Garikipati VNS; Elrod JW; Koch WJ; Kishore R
Theranostics; 2022; 12(9):4415-4430. PubMed ID: 35673580
[No Abstract] [Full Text] [Related]
18. First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential.
Balbi C; Piccoli M; Barile L; Papait A; Armirotti A; Principi E; Reverberi D; Pascucci L; Becherini P; Varesio L; Mogni M; Coviello D; Bandiera T; Pozzobon M; Cancedda R; Bollini S
Stem Cells Transl Med; 2017 May; 6(5):1340-1355. PubMed ID: 28271621
[TBL] [Abstract][Full Text] [Related]
19. Stem Cells-Derived Extracellular Vesicles: Potential Therapeutics for Wound Healing in Chronic Inflammatory Skin Diseases.
Manchon E; Hirt N; Bouaziz JD; Jabrane-Ferrat N; Al-Daccak R
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808520
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles Work as a Functional Inflammatory Mediator Between Vascular Endothelial Cells and Immune Cells.
Hosseinkhani B; Kuypers S; van den Akker NMS; Molin DGM; Michiels L
Front Immunol; 2018; 9():1789. PubMed ID: 30131806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
